XML 28 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments and Fair Value Measurements
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Financial Instruments and Fair Value Measurements

8. Financial Instruments and Fair Value Measurements

The fair value of an asset is defined as the exit price, which is the amount that would either be received when an asset is sold or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The guidance establishes a three-tier fair value hierarchy based on the inputs used in measuring fair value. These tiers are: Level 1, for which quoted market prices for identical instruments are available in active markets, such as money market funds, equity securities, and U.S. Treasury securities; Level 2, for which there are inputs other than quoted prices included within Level 1 that are observable for the instrument, such as certain derivative instruments including interest rate caps and interest rate swaps; and Level 3, for financial instruments or other assets/liabilities that do not fall into Level 1 or Level 2 and for which little or no market data exists, therefore requiring the Company to develop its own assumptions.

Items Measured at Fair Value on a Recurring Basis

The methods and assumptions described below were used to estimate the fair value of each class of financial instrument. For significant Level 3 items, the Company has also provided the unobservable inputs along with their weighted-average ranges.

Money Market Funds — The Company has money market funds, which are included in Cash and cash equivalents in the consolidated financial statements, are comprised of government securities and/or U.S. Treasury bills. These funds were classified as Level 1 as we used quoted prices from active markets to determine their fair values.

Equity Investments – The Company’s Investment in Albertsons became publicly traded during 2020 (Note 4). Upon Albertsons’ IPO, this investment has a readily determinable market value (traded on an exchange) and is being accounted for as a Level 1 investment.

Derivative Assets — The Company has derivative assets, which are included in Other assets, net in the consolidated financial statements, and are comprised of interest rate swaps and caps. The derivative instruments were measured at fair value using readily observable market inputs, such as quotations on interest rates, and were classified as Level 2 as these instruments are custom, over-the-counter contracts with various bank counterparties that are not traded in an active market. See “Derivative Financial Instruments,” below.

Derivative Liabilities — The Company has derivative liabilities, which are included in Accounts payable and other liabilities in the consolidated financial statements, and are comprised of interest rate swaps. These derivative instruments were measured at fair value using readily observable market inputs, such as quotations on interest rates, and were classified as Level 2 because they are custom, over-the-counter contracts with various bank counterparties that are not traded in an active market. See “Derivative Financial Instruments,” below.

The Company did not have any transfers into or out of Level 1, Level 2, and Level 3 measurements during the six months ended June 30, 2020 or 2019.

The following table presents the Company’s fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (in thousands):

 

 

June 30, 2020

 

 

December 31, 2019

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Derivative financial instruments

 

 

 

 

 

10

 

 

 

 

 

 

 

 

 

2,583

 

 

 

 

Investment in Albertsons (Note 4)

 

 

64,937

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial instruments

 

 

 

 

 

109,040

 

 

 

 

 

 

 

 

 

39,061

 

 

 

 

 

In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Items Measured at Fair Value on a Nonrecurring Basis (Including Impairment Charges)

During March of 2020, the Company was impacted by the COVID-19 Pandemic (Note 11), which caused the Company to re-evaluate its holding periods and forecasted operating income at certain properties. As a result, several impairments were recorded at Fund assets. Impairment charges for the periods presented are as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

Impairment Charge

 

Property and Location

 

Owner

 

Triggering Event

 

Level 3 Inputs

 

Effective Date

 

Total

 

 

Acadia's Share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2020 Impairment Charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cortlandt Crossing, Mohegan Lake, NY

 

Fund III

 

Reduced holding period, reduced projected operating income

 

Projections of: holding period, net operating income, cap rate, incremental costs

 

3/31/2020

 

$

27,402

 

 

$

6,726

 

654 Broadway, New York, NY

 

Fund III

 

Reduced holding period

 

Projections of: holding period, net operating income, cap rate, incremental costs

 

3/31/2020

 

 

6,398

 

 

 

1,570

 

146 Geary Street, San Francisco, CA

 

Fund IV

 

Reduced holding period, reduced projected operating income

 

Projections of: holding period, net operating income, cap rate, incremental costs

 

3/31/2020

 

 

6,718

 

 

 

1,553

 

801 Madison Avenue, New York, NY

 

Fund IV

 

Reduced holding period, reduced projected operating income

 

Projections of: holding period, net operating income, cap rate, incremental costs

 

3/31/2020

 

 

11,031

 

 

 

2,551

 

Total 2020 Impairment Charges

 

 

 

 

 

 

 

 

 

$

51,549

 

 

$

12,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019 Impairment Charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

210 Bowery residential units

 

Fund IV

 

Reduced selling price

 

Contract sales price

 

9/30/2019

 

$

321

 

 

$

74

 

210 Bowery residential units

 

Fund IV

 

Reduced selling price

 

Offering price

 

6/30/2019

 

 

1,400

 

 

 

321

 

Total 2019 Impairment Charges

 

 

 

 

 

 

 

 

 

$

1,721

 

 

$

395

 

Derivative Financial Instruments

The Company had the following interest rate swaps and caps for the periods presented (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Strike Rate

 

 

 

 

Fair Value

 

Derivative

Instrument

 

Aggregate Notional Amount

 

 

Effective Date

 

 

Maturity Date

 

 

Low

 

 

 

 

High

 

 

Balance Sheet

Location

 

June 30,

2020

 

 

December 31,

2019

 

Core

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Rate Swaps

 

$

522,800

 

 

Dec 2012-Apr 2023

 

 

Jan 2021-Apr 2033

 

 

 

1.24

%

 

 

 

3.77

%

 

Other Liabilities (a)

 

$

(89,962

)

 

$

(33,750

)

Interest Rate Swaps

 

 

39,235

 

 

Jan 2016

 

 

Jul 2020

 

 

 

1.29

%

 

 

 

1.29

%

 

Other Assets

 

 

 

 

 

456

 

 

 

$

562,035

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

(89,962

)

 

$

(33,294

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fund II

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Rate Swap

 

$

18,941

 

 

Oct 2014

 

 

Nov 2021

 

 

 

2.88

%

 

 

 

2.88

%

 

Other Liabilities

 

$

(349

)

 

$

(139

)

Interest Rate Cap

 

 

45,000

 

 

Mar 2019

 

 

Mar 2022

 

 

 

3.50

%

 

 

 

3.50

%

 

Other Assets

 

 

9

 

 

 

1

 

 

 

$

63,941

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

(340

)

 

$

(138

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fund III

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Rate Cap

 

$

39,470

 

 

Jan 2020

 

 

Jan 2021

 

 

 

3.00

%

 

 

 

3.00

%

 

Other Assets

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fund IV

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Rate Swaps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Assets

 

 

 

 

$

22

 

Interest Rate Swaps

 

 

67,244

 

 

Mar 2017 - Dec 2019

 

 

Apr 2022 - Dec 2022

 

 

 

1.48

%

 

 

 

4.00

%

 

Other Liabilities

 

 

(2,335

)

 

 

(812

)

Interest Rate Caps

 

 

90,600

 

 

July 2019 - Dec 2019

 

 

Dec 2020 - July 2021

 

 

 

3.00

%

 

 

 

3.50

%

 

Other Assets

 

 

1

 

 

 

 

 

 

$

157,844

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

(2,334

)

 

$

(790

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fund V

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Rate Swaps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Assets

 

 

 

 

$

2,104

 

Interest Rate Swaps

 

 

334,505

 

 

Jan 2018-Nov 2019

 

 

Feb 2021-Oct 2024

 

 

 

1.25

%

 

 

 

2.88

%

 

Other Liabilities

 

 

(16,394

)

 

 

(4,360

)

 

 

$

334,505

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

(16,394

)

 

$

(2,256

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total asset derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

10

 

 

$

2,583

 

Total liability derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

(109,040

)

 

$

(39,061

)

 

 

(a)

Includes two swaps with an aggregate fair value of ($27.0) million and ($11.8) million at June 30, 2020 and December 31, 2019, respectively, which were acquired during July 2018 with a notional value of $125.0 million and are not effective until July 2020. Includes one swap with an aggregate value of ($3.2) million at June 30, 2020, which was acquired during February 2020 with a notional value of $50.0 million and is not effective until April 2023. Includes one swap with an aggregate fair value of ($2.9) million at June 30, 2020, which was acquired during February 2020 with a notional value of $50.0 million and is not effective until April 2023.

 

All of the Company’s derivative instruments have been designated as cash flow hedges and hedge the future cash outflows on variable-rate debt (Note 7). It is estimated that approximately $20.2 million included in accumulated other comprehensive (loss) income related to derivatives will be reclassified to interest expense within the next twelve months. As of June 30, 2020 and December 31, 2019, no derivatives were designated as fair value hedges or hedges of net investments in foreign operations. Additionally, the Company does not use derivatives for trading or speculative purposes and currently does not have any derivatives that are not designated hedges.

Risk Management Objective of Using Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources and duration of its debt funding and, from time to time, through the use of derivative financial instruments. The Company enters into derivative financial instruments to manage exposures that result in the receipt or payment of future known and uncertain cash amounts, the values of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s investments and borrowings.

The Company is exposed to credit risk in the event of non-performance by the counterparties to the swaps if the derivative position has a positive balance. The Company believes it mitigates its credit risk by entering into swaps with major financial institutions. The Company continually monitors and actively manages interest costs on its variable-rate debt portfolio and may enter into additional interest rate swap positions or other derivative interest rate instruments based on market conditions. 

Credit Risk-Related Contingent Features

The Company has agreements with each of its swap counterparties that contain a provision whereby if the Company defaults on certain of its unsecured indebtedness, the Company could also be declared in default on its swaps, resulting in an acceleration of payment under the swaps.

Other Financial Instruments

The Company’s other financial instruments had the following carrying values and fair values as of the dates shown (dollars in thousands, inclusive of amounts attributable to noncontrolling interests where applicable):

 

 

 

 

 

 

 

June 30, 2020

 

 

December 31, 2019

 

 

 

Level

 

 

Carrying

Amount

 

 

Estimated

Fair Value

 

 

Carrying

Amount

 

 

Estimated

Fair Value

 

Notes Receivable (a)

 

 

3

 

 

$

135,562

 

 

$

136,003

 

 

$

114,943

 

 

$

113,422

 

Mortgage and Other Notes Payable (a)

 

 

3

 

 

 

1,168,484

 

 

 

1,151,567

 

 

 

1,179,503

 

 

 

1,191,281

 

Investment in non-traded equity securities (b)

 

 

3

 

 

 

2,019

 

 

 

1,654

 

 

 

1,778

 

 

 

57,964

 

Unsecured notes payable and Unsecured line of credit (c)

 

 

2

 

 

 

650,195

 

 

 

631,555

 

 

 

538,425

 

 

 

539,362

 

 

(a)

The Company determined the estimated fair value of these financial instruments using a discounted cash flow model with rates that take into account the credit of the borrower or tenant, where applicable, and interest rate risk. The Company also considered the value of the underlying collateral, taking into account the quality of the collateral, the credit quality of the borrower, the time until maturity and the current market interest rate environment.

(b)

Represents the Operating Partnership’s cost-method investment in Fifth Wall (Note 4). Fair value as of December 31, 2019 also represents Mervyns II’s cost-method investment in Albertsons’ supermarkets, which is carried at fair value at June 30, 2020 and, therefore, is no longer reflected in the table above.

(c)

The Company determined the estimated fair value of the unsecured notes payable and unsecured line of credit using quoted market prices in an open market with limited trading volume where available. In cases where there was no trading volume, the Company determined the estimated fair value using a discounted cash flow model using a rate that reflects the average yield of similar market participants.

The Company’s cash and cash equivalents, restricted cash, accounts receivable, accounts payable and certain financial instruments included in other assets and other liabilities had fair values that approximated their carrying values due to their short maturity profiles at June 30, 2020.